Novartis Unit Seeks £11.3M Damages Over Invalidated Patent
A Novartis subsidiary slapped a Pfizer unit with a claim in the U.K. for more than £11.3 million ($14.6 million) in damages it says it suffered from infringement litigation over a...To view the full article, register now.
Already a subscriber? Click here to view full article